🔴 Insulet Corporation is trading 4.1% down today following a voluntary device correction for its Omnipod pods

Insulet Corporation is trading 4.1% down today at $142.00 after the company initiated a voluntary medical device correction for certain lots of its Omnipod insulin delivery pods.

• The correction is due to a manufacturing defect that could cause a small tear in the tubing, leading to insulin leakage and under-delivery.
• This action affects specific lots of Omnipod 5, Omnipod DASH, and the Omnipod Insulin Management System.
• While this news is driving today's downturn, a Zacks article on June 2, 2026, highlighted Insulet as a top-ranked growth stock, indicating some positive underlying sentiment prior to the full impact of the device correction news.